Literature DB >> 21053080

Is more better? Outcome and dose of a universal drug prevention effectiveness trial.

Laura Ferrer-Wreder1, Hans Saint-Eloi Cadely, Celene E Domitrovich, Meg L Small, Linda L Caldwell, Michael J Cleveland.   

Abstract

Two evidence-based interventions, Life Skills Training and TimeWise, were combined in an effectiveness trial. Participants were predominately African American youth (N = 715; M (age) = 12). The study authors provide an empirical demonstration of the implications of incorporating dosage information in intervention outcome analyses. Study results showed no program-related benefits for drug use. Results indicated intervention-related benefits for assertiveness and anxiety management skills and drug use intentions as well as a reduction in detrimental leisure motivations. High program exposure and lesson coverage tended to be connected to intervention benefits. Study findings also documented ways that dosage information provides insight into interventions and their effects.

Entities:  

Mesh:

Year:  2010        PMID: 21053080      PMCID: PMC4060792          DOI: 10.1007/s10935-010-0226-4

Source DB:  PubMed          Journal:  J Prim Prev        ISSN: 0278-095X


  17 in total

1.  Smoking prevention among urban minority youth: assessing effects on outcome and mediating variables.

Authors:  G J Botvin; L Dusenbury; E Baker; S James-Ortiz; E M Botvin; J Kerner
Journal:  Health Psychol       Date:  1992       Impact factor: 4.267

2.  Current and future challenges in school-based prevention: the researcher perspective.

Authors:  Mark T Greenberg
Journal:  Prev Sci       Date:  2004-03

3.  Preventing adolescent drug abuse through a multimodal cognitive-behavioral approach: results of a 3-year study.

Authors:  G J Botvin; E Baker; L Dusenbury; S Tortu; E M Botvin
Journal:  J Consult Clin Psychol       Date:  1990-08

4.  A skills training approach to smoking prevention among Hispanic youth.

Authors:  G J Botvin; L Dusenbury; E Baker; S James-Ortiz; J Kerner
Journal:  J Behav Med       Date:  1989-06

5.  Standards of evidence: criteria for efficacy, effectiveness and dissemination.

Authors:  Brian R Flay; Anthony Biglan; Robert F Boruch; Felipe González Castro; Denise Gottfredson; Sheppard Kellam; Eve K Mościcki; Steven Schinke; Jeffrey C Valentine; Peter Ji
Journal:  Prev Sci       Date:  2005-09

Review 6.  Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation.

Authors:  Joseph A Durlak; Emily P DuPre
Journal:  Am J Community Psychol       Date:  2008-06

7.  A cognitive-behavioral approach to substance abuse prevention: one-year follow-up.

Authors:  G J Botvin; E Baker; A D Filazzola; E M Botvin
Journal:  Addict Behav       Date:  1990       Impact factor: 3.913

8.  Characteristics of effective school-based substance abuse prevention.

Authors:  Denise C Gottfredson; David B Wilson
Journal:  Prev Sci       Date:  2003-03

Review 9.  What works in prevention. Principles of effective prevention programs.

Authors:  Maury Nation; Cindy Crusto; Abraham Wandersman; Karol L Kumpfer; Diana Seybolt; Erin Morrissey-Kane; Katrina Davino
Journal:  Am Psychol       Date:  2003 Jun-Jul

10.  Long-term follow-up results of a randomized drug abuse prevention trial in a white middle-class population.

Authors:  G J Botvin; E Baker; L Dusenbury; E M Botvin; T Diaz
Journal:  JAMA       Date:  1995-04-12       Impact factor: 56.272

View more
  2 in total

1.  Reducing Risk Behavior with Family-Centered Prevention During the Young Adult Years.

Authors:  Elizabeth Stormshak; Allison Caruthers; Krista Chronister; David DeGarmo; Jenna Stapleton; Corrina Falkenstein; Elisa DeVargas; Whitney Nash
Journal:  Prev Sci       Date:  2019-04

2.  Building Bridges to a Brighter Tomorrow: A Systematic Evidence Review of Interventions That Prepare Adolescents for Adulthood.

Authors:  Barri B Burrus; Kathleen Krieger; Regina Rutledge; Alexander Rabre; Sarah Axelson; Audra Miller; LeBretia White; Christine Jackson
Journal:  Am J Public Health       Date:  2018-02       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.